Literature DB >> 24895030

Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak.

E Laffon1, F Lamare, H de Clermont, I A Burger, R Marthan.   

Abstract

OBJECTIVES: To assess variability of the average standard uptake value (SUV) computed by varying the number of hottest voxels within an (18)F-fluorodeoxyglucose ((18)F-FDG)-positive lesion. This SUV metric was compared with the maximal SUV (SUV(max): the hottest voxel) and peak SUV (SUV(peak): SUV(max) and its 26 neighbouring voxels).
METHODS: Twelve lung cancer patients (20 lesions) were analysed using PET dynamic acquisition involving ten successive 2.5-min frames. In each frame and lesion, average SUV obtained from the N = 5, 10, 15, 20, 25 or 30 hottest voxels (SUV(max-N)), SUV(max) and SUV(peak) were assessed. The relative standard deviations (SDrs) from ten frames were calculated for each SUV metric and lesion, yielding the mean relative SD from 20 lesions for each SUV metric (SDr(N), SDr(max) and SDr(peak)), and hence relative measurement error and repeatability (MEr-R).
RESULTS: For each N, SDr(N) was significantly lower than SDr(max) and SDr(peak). SDr(N) correlated strongly with N: 6.471 × N(-0.103) (r = 0.994; P < 0.01). MEr-R of SUV(max-30) was 8.94-12.63% (95% CL), versus 13.86-19.59% and 13.41-18.95% for SUV(max) and SUV(peak) respectively.
CONCLUSIONS: Variability of SUV(max-N) is significantly lower than for SUV(max) and SUV(peak). Further prospective studies should be performed to determine the optimal total hottest volume, as voxel volume may depend on the PET system. KEY POINTS: • PET imaging provides functional parameters of (18) F-FDG-positive lesions, such as SUVmax and SUVpeak. • Averaging SUV from several hottest voxels (SUVmax-N) is a further SUV metric. • Variability of SUVmax-N is significantly lower than SUVmax and SUVpeak variability. • SUVmax-N should improve SUV accuracy for predicting outcome or assessing treatment response. • An optimal total hottest volume should be determined through further prospective studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24895030     DOI: 10.1007/s00330-014-3222-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  25 in total

Review 1.  Standards for PET image acquisition and quantitative data analysis.

Authors:  Ronald Boellaard
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

2.  Variability of total lesion glycolysis by 18F-FDG-positive tissue thresholding in lung cancer.

Authors:  Eric Laffon; Henri de Clermont; Frederic Lamare; Roger Marthan
Journal:  J Nucl Med Technol       Date:  2013-08-05

3.  Variability of ¹⁸F-FDG-positive lung lesion volume by thresholding.

Authors:  Eric Laffon; Henri de Clermont; Roger Marthan
Journal:  Eur Radiol       Date:  2012-10-20       Impact factor: 5.315

4.  Repeatability of FDG quantification in tumor imaging: averaged SUVs are superior to SUVmax.

Authors:  Irene A Burger; Dominic M Huser; Cyrill Burger; Gustav K von Schulthess; Alfred Buck
Journal:  Nucl Med Biol       Date:  2012-03-03       Impact factor: 2.408

5.  Impact of the definition of peak standardized uptake value on quantification of treatment response.

Authors:  Matt Vanderhoek; Scott B Perlman; Robert Jeraj
Journal:  J Nucl Med       Date:  2012-01       Impact factor: 10.057

6.  Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology.

Authors:  Mathieu Hatt; Dimitris Visvikis; Nidal M Albarghach; Florent Tixier; Olivier Pradier; Catherine Cheze-le Rest
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-02       Impact factor: 9.236

Review 7.  PET/CT imaging in different types of lung cancer: an overview.

Authors:  Valentina Ambrosini; Silvia Nicolini; Paola Caroli; Cristina Nanni; Arianna Massaro; Maria Cristina Marzola; Domenico Rubello; Stefano Fanti
Journal:  Eur J Radiol       Date:  2011-03-31       Impact factor: 3.528

8.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

9.  Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET.

Authors:  Perrine Tylski; Simon Stute; Nicolas Grotus; Kaya Doyeux; Sébastien Hapdey; Isabelle Gardin; Bruno Vanderlinden; Irène Buvat
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

10.  Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.

Authors:  R L Wahl; K Zasadny; M Helvie; G D Hutchins; B Weber; R Cody
Journal:  J Clin Oncol       Date:  1993-11       Impact factor: 44.544

View more
  9 in total

1.  Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and Marthan.

Authors:  Dirk Hasenclever; Lars Kurch; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11       Impact factor: 9.236

2.  Interim FDG PET scans in lymphoma: SUV measurement error may impair qPET methodology.

Authors:  Eric Laffon; Roger Marthan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-12       Impact factor: 9.236

3.  Reply to E. Laffon et al.

Authors:  Clément Bailly; Thomas Carlier; Françoise Kraeber-Bodéré; Steven Le Gouill; Caroline Bodet-Milin
Journal:  Haematologica       Date:  2020-01       Impact factor: 9.941

4.  Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic 18F-FMISO PET for Head and Neck Cancer Radiotherapy.

Authors:  Daniela Thorwarth; Stefan Welz; David Mönnich; Christina Pfannenberg; Konstantin Nikolaou; Matthias Reimold; Christian La Fougère; Gerald Reischl; Paul-Stefan Mauz; Frank Paulsen; Markus Alber; Claus Belka; Daniel Zips
Journal:  J Nucl Med       Date:  2019-05-10       Impact factor: 10.057

5.  On the 18F-fluoride PET imaging quantification to predict 223Ra-dichloride treatment response.

Authors:  Eric Laffon; Henri de Clermont; Roger Marthan; Fredéric Paycha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-04       Impact factor: 9.236

6.  Quantitative performance and optimal regularization parameter in block sequential regularized expectation maximization reconstructions in clinical 68Ga-PSMA PET/MR.

Authors:  Edwin E G W Ter Voert; Urs J Muehlematter; Gaspar Delso; Daniele A Pizzuto; Julian Müller; Hannes W Nagel; Irene A Burger
Journal:  EJNMMI Res       Date:  2018-07-27       Impact factor: 3.138

7.  Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination.

Authors:  Brigitte Fuenfgeld; Philipp Mächler; Dorothee R Fischer; Giuseppe Esposito; Elisabeth Jane Rushing; Philipp A Kaufmann; Paul Stolzmann; Martin W Huellner
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

8.  Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary 18F-NaF PET.

Authors:  Martin Lyngby Lassen; Jacek Kwiecinski; Damini Dey; Sebastien Cadet; Guido Germano; Daniel S Berman; Philip D Adamson; Alastair J Moss; Marc R Dweck; David E Newby; Piotr J Slomka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-05       Impact factor: 9.236

9.  Concurrent imaging of vascularization and metabolism in a mouse model of paraganglioma under anti-angiogenic treatment.

Authors:  Caterina Facchin; Mailyn Perez-Liva; Anikitos Garofalakis; Thomas Viel; Anais Certain; Daniel Balvay; Thulaciga Yoganathan; Justine Woszczyk; Kelly De Sousa; Joevin Sourdon; Jean Provost; Mickael Tanter; Charlotte Lussey-Lepoutre; Judith Favier; Bertrand Tavitian
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.